Sir, Photodynamic Therapy of Choroidal Haemangioma Associated with Sturge-Weber Syndrome
Choroidal haemangioma is an uncommon benign vascular tumour of the choroid that can be either circumscribed or diffuse.
1 Diffuse choroidal haemangioma is usually part of neuro-oculo-cutaneous haemangiomatosis (Sturge-Weber syndrome). The diffuse choroidal haemangioma of Sturge-Weber syndrome may have localized areas of excessive thickening simulating a circumscribed choroidal haemangioma. 2 Diffuse choroidal haemangioma can lead to visual loss due to refractive errors, foveal distortion, and exudative retinal detachment.
1 Tumour regression and resolution of subretinal fluid can be induced with low-dose radiotherapy 3 or proton beam radiotherapy. 4 Photodynamic therapy (PDT) is currently being advocated for circumscribed choroidal haemangioma with good short-term results. 5 In this report we present our initial experience of treating a choroidal haemangioma with PDT in the setting of Sturge-Weber syndrome.
A 31-year-old female who was 15 weeks pregnant and was known to have Sturge-Weber syndrome, presented with reduced vision in the left eye of 6 weeks duration (Figure 1a) . On examination the uncorrected visual acuity was 6/5 in the right eye and 6/120 in the left eye. The right eye was normal. Anterior segment examination of the left eye showed prominent episcleral vessels with normal intraocular pressure. Fundus examination revealed diffuse choroidal thickening with a more prominent localized thickening in the temporal quadrant (Figure 1b) . The localized component was about 12 mm in basal dimension and its posterior margin involved the foveola. There was minimal exudative retinal detachment but no cystoid macular oedema. On B-scan ultrasonography the haemangioma had a maximal thickness of 5.6 mm (Figure 1c) .
Following detailed discussions regarding various therapeutic options, it was elected to cautiously observe because of pregnancy. She remained unchanged on clinical and ultrasonographic examination without any spontaneous improvement 4 months following delivery. 6 Because of concerns for long-term visual loss and encouraged by the response of circumscribed choroidal haemangioma to PDT, 7-9 she was treated with PDT. A standard dose of verteporfin (6 mg/m 2 ) was given as an intravenous infusion over 5 min immediately followed by diode laser (690 nm) applications of 2500 mm size, intensity of 600 mW/cm 2 , and exposure of 83 s (50 mJ/cm 2 ). Altered haemodynamics with high flow through the haemangioma led us to infuse verteporfin over a shorter period (5 min as compared to 10 min) and perform PDT soon thereafter instead of waiting for 5 min after completion of the infusion.
In total, five contiguous spots were applied to the posterior half of the circumscribed portion in a single setting with a Volk PDT lens. On the following day she noted a reduction of vision to hand motions which was recorded on examination a week later. It was attributed to exudative retinal detachment that involved the lower half of the retina and extended up to the foveola. The corrected visual acuity gradually improved over 6 months to 6/6 with complete resolution of subretinal fluid (Figure 1d ). Moderate prominence of retinal pigmentation at the treatment site with corresponding flattening of the choroidal haemangioma was evident (Figure 1e) .
The decision to treat diffuse choroidal haemangioma should be individualized based upon the extent of symptoms, visual loss, and potential for visual recovery. The aim of the treatment is to induce tumour atrophy, resolution of subretinal fluid, and minimize tumor induced foveal distortion. As compared to various forms of radiotherapy, PDT has the advantage of avoiding radiation, ease of delivery, and minimal side effects. Our case illustrates that in addition to circumscribed choroidal haemangioma, selected cases of diffuse choroidal haemangioma are amenable to treatment with PDT. Long-term observations on treated patients are necessary to fully evaluate the efficacy of PDT. Sir, Severe bilateral posterior ischemic optic neuropathy as a complication of spinal surgery
Posterior ischemic optic neuropathy (PION) is a rare but visually devastating complication of surgery. PION has been reported following many different procedures, including spinal surgery, liver transplantation, hip replacement, and peritoneal dialysis. 1- 4 We report a case of severe bilateral PION following spinal surgery.
Case report
A 55-year-old white female underwent spinal fusion surgery for spondylosis at the level of L4-L5 and L5-S1 vertebrae for severe persistent back and leg pain. Her past medical history was significant for osteoarthritis and mitral valve prolapse with no significant ophthalmic problem. The procedure was performed in the prone position with her head supported by a rest designed to avoid direct pressure on the face. The operative course was complicated and longer than expected, lasting 11 1 2 hours. Intraoperatively her haematocrit fell from 42.1 to 27.3. The mean arterial pressure during the case was maintained between 60 and 100 mmHg, with the majority of time being between 65 and 75 mm of Hg.
Upon recovery from surgery, the patient reported an inability to see with either eye. Initial examination revealed no light perception (NLP) in both eyes. Pupils were symmetric at 6 mm with poor reaction bilaterally. There was a slight left afferent pupillary defect (APD). External exam was unremarkable except for mild bilateral periorbital oedema. Dilated examination revealed a normal fundus bilaterally. No disc swelling, haemorrhages, or pallor was detected. High-dose IV dexamethasone was administered, and immediate CT scan of her head and subsequent MRI/MRA of the head with and without contrast were unremarkable. The patient was started on IV Solumedrol.
She had recovered light perception (LP) in her right eye but remained NLP in her left eye 36 h after surgery. Serial examinations over the following months revealed progressive pallor to both optic nerves. At 2 months after the initial episode, the Goldmann visual field revealed only a small island of vision in the superotemporal quadrant of her right eye (Figure 1 inset) . 
